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Background: Binge eating disorder (BED) is a prevalent clinical eating disorder associated with increased
psychopathology, psychiatric comorbidity, overweight and obesity, and increased health care costs. Since its
inclusion in the DSM-IV, a few randomized controlled trials (RCTs) have suggested efficacy of book-based self-help
interventions in the treatment of this disorder. However, evidence from larger RCTs is needed. Delivery of self-help
through new technologies such as the internet should be investigated in particular, as these approaches have the
potential to be more interactive and thus more attractive to patients than book-based approaches. This study will
evaluate the efficacy of an internet-based guided self-help program (GSH-I) and cognitive-behavioral therapy (CBT),
which has been proven in several studies to be the gold standard treatment for BED, in a prospective multicenter
randomized trial.
Methods: The study assumes the noninferiority of GSH-I compared to CBT. Both treatments lasted 4 months, and
maintenance of outcome will be assessed 6 and 18 months after the end of treatment. A total of 175 patients with
BED and a body mass index between 27 and 40 kg/m2 were randomized at 7 centers in Germany and Switzerland.
A 20% attrition rate was assumed. As in most BED treatment trials, the difference in the number of binge eating
days over the past 28 days is the primary outcome variable. Secondary outcome measures include the specific
eating disorder psychopathology, general psychopathology, body weight, quality of life, and self-esteem. Predictors
and moderators of treatment outcome will be determined, and the cost-effectiveness of both treatment conditions
will be evaluated.
Results: The methodology for the INTERBED study has been detailed.
Conclusions: Although there is evidence that CBT is the first-line treatment for BED, it is not widely available. As
BED is still a recent diagnostic category, many cases likely remain undiagnosed, and a large number of patients
either receive delayed treatment or never get adequate treatment. A multicenter efficacy trial will give insight into
the efficacy of a new internet-based guided self-help program and will allow a direct comparison to the
evidence-based gold standard treatment of CBT in Germany.
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Binge eating disorder (BED) is a research diagnosis in
the Diagnostic and Statistical Manual of Mental Disor-
ders, Fourth Edition (DSM-IV) [1]. BED is defined by re-
current binge eating episodes that occur, in contrast
with those in bulimia nervosa, in the absence of inappro-
priate weight control behaviors (for example, purging).
A series of characteristics are associated with binge eat-
ing, such as rapid consumption of food, eating until un-
comfortably full, and marked distress regarding the
behavior. For a BED diagnosis, binge eating episodes
must have occurred at least twice weekly over a period
of 6 months.
International experts for eating disorders agree that
BED is a valid eating disorder diagnosis and should be
included in DSM-5 as an official diagnosis [2]. BED is
the most prevalent eating disorder, affecting 2% to 5% of
the general population, and both genders appear to be
equally affected [3]. The disorder is associated with sub-
stantial medical [4] and psychological comorbidities [5].
Furthermore, overweight and obesity are common in
patients with BED. Up to 30% of participants in weight
loss programs meet criteria for BED [6], and higher
levels of binge eating have been linked to overweight
and obesity [7]. Obese patients with BED display marked
eating disorder psychopathology and comorbidity with
other psychiatric disorders. Given the associated comor-
bid somatic and mental sequelae, BED is argued to be a
disorder of clinical significance causing huge costs for
the medical system [8].
According to current meta-analyses and clinical treat-
ment guidelines, cognitive-behavioral therapy (CBT) is
regarded as the first-line specialty treatment for BED
[9-13]. Controlled studies of CBT generally report sub-
stantial reductions in binge eating and in most asso-
ciated problems such as comorbid psychopathology and
impaired quality of life [13].
Although CBT is the gold standard treatment for BED
patients, this intervention is not offered areawide, lead-
ing to delayed delivery of adequate treatment. An alter-
native to classic face-to-face CBT and a potential means
by which to disseminate adequate treatment for eating
disorders is guided or pure self-help for patients with
BED. So far only a few open studies or RCTs have evalu-
ated self-help interventions in BED [7,14-20]. Nearly all
of them used book-based self-help with manuals detail-
ing CBT for binge eating, primarily the book Overcoming
Binge Eating [21]. One study used a CD-ROM-based
self-help intervention [18]. Results of single studies,
meta-analyses, and systematic reviews [13,22-24] have
shown that guided self-help is superior to waiting list in
patients with BED. Patients using self-help modalities
did better than controls in reducing days with objective
binge eating episodes (OBEs), in reducing hours spentbinge eating, and in improving the specific eating dis-
order psychopathology [15]. However, the evidence
regarding guided self-help is limited to a small number
of studies, and further, larger randomized-controlled
studies (RCTs) are needed.
Several experts have outlined potential advantages of
guided self-help treatments. (1) They allow evidence-
based treatments to be offered with minimum delay. (2)
They are popular and acceptable to many patients. (3)
They can be offered at low cost. (4) They respect
patients’ privacy and avoid their embarrassment about
needing psychotherapy. (5) They allow patients to work
at their own pace, which is particularly important for
highly anxious or depressed patients who have difficulty
to focus during a session with a therapist. (6) They allow
patients to renew or update treatment as often as they
wish and at no extra cost. (7) They could be appropriate
for less severe conditions in primary care delivered by
trained nonspecialists or could be the first step in
patients’ search for a more comprehensive treatment.
Only one study directly compared guided self-help
with face-to-face psychotherapy [19]. In this trial, inter-
personal psychotherapy (IPT; n = 75) and guided self-
help based on CBT using a book-based format (n = 66)
were equally effective, with 4-week abstinence rates from
OBEs in more than 60% of the patients that were main-
tained over a follow-up period of 4 years [25]. However,
IPT was more successful than self-help in retaining
patients in the trial. Moderator analyses provided evi-
dence for a specificity of treatment effects; for example,
a high baseline binge eating frequency had a negative
impact on remission rates in the guided self-help condi-
tion, but not in the IPT condition.
Until recently, little has been done on technology-
enhanced delivery of CBT-based interventions for BED.
In a RCT comparing the efficacy of a 10-week CD-ROM
intervention, a group CBT, and a waiting list, there were
comparable reductions in days with OBEs in the group
CBT and in the CD-ROM condition, with better results
in the two active intervention groups compared to the
waiting list [18]. However, the conclusions of this study
were limited by a high rate of dropout. At present, there
is only one internet-based BED treatment study com-
paring a guided self-help approach with a waiting list
[20]. Seventy-four women were randomized to either a
6-month online program with a 6-month follow-up or a
6-month waiting list. Guidance consisted of regular
e-mail contact with a coach during the whole inter-
vention. The number of OBEs and eating disorder psy-
chopathology significantly improved after the internet
self-help treatment intervention. Improvements were
maintained at 6-month follow-up. Overall, a transfer of
CBT-based self-help techniques to the internet was well-
accepted by patients and showed positive results for
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it was their first eating disorder treatment. However,
internet-based, guided self-help has not yet been directly
compared with standard face-to-face CBT.
An additional important question is for whom the
face-to-face and self-help modalities of CBT work [10].
Evidence from the planned treatment trial would allow
specifying how to adequately match patients with treat-
ments. A comparison of previous studies did not show
any clear difference in moderators for both face-to-face
and self-help modalities of CBT. More severe eating dis-
order psychopathology and general psychopathology in-
consistently predicted poor treatment outcome in both
modalities [26]. From a stepped care approach, as
advanced by the National Institute for Clinical Excel-
lence guidelines [11], patients with more severe psycho-
pathology should benefit more from face-to-face CBT,
whereas internet-based guided self-help should be suffi-
cient for patients with low psychopathology. Further
variables with at least some evidence for predictive
effects on treatment outcome are psychiatric comorbid-
ity, self-esteem, quality of life, age at onset of the eating
disorder or of overweight, and patient expectation and
motivation (for a summary, see [27]).
The main goal of internet-based guided self-help for
overweight and obese patients with binge eating disorder
(INTERBED) is to compare the short- and long-term
outcomes of two treatments for adult patients with BED:
internet-based guided self-help treatment (GSH-I) and
CBT in an individual setting. In addition, we will investi-
gate predictors and moderators of treatment outcome.
Finally, we will evaluate the cost-effectiveness of both
treatments.
Methods
General design aspects
INTERBED is a multicenter, randomized, noninferiority
trial with two parallel arms designed to evaluate, in an
independent and blinded study, the efficacy of GSH-I
and CBT (principal investigator (PI): MdZ; co-PI: AH).
The treatment phase will last 4 months per participant.
A maximum of 6 weeks can be added in case of longer
therapy intervals due to factors such as illness or vac-
ation. Study enrollment was started in August 2010 and
finished in March 2012. After randomization, baseline
assessment was conducted (T0) prior to the start of
therapy, and within 2 weeks participants started treat-
ment in either the GSH-I or the CBT arm.
Participants then received 20 individual face-to-face
treatment sessions with a therapist (CBT) or had 17 to
18 e-mail contacts and 2 personal contacts with a coach
(GSH-I) over a period of 4 months. The number of days
on which OBEs occurred were assessed at midtreatment,
at month 2 (GSH-I), or after 10 therapy sessions (CBT)(T1), as well as after the completion of treatment (T2).
Both treatments lasted 4 months, and maintenance of
outcome will be assessed 6 months and 18 months after
the end of treatment (T3 and T4).
Study centers and participants
The study is being conducted at seven trial sites, all of
which are running well-established outpatient clinics. All
participants have been registered at the outpatient clinics
of the trial sites. Participating centers are the Departments
of Psychosomatic Medicine and Psychotherapy of the
Universities of Bochum (PI: SH), Erlangen-Nuremberg
(PI: MdZ), Heidelberg (PI: HCF), and Tübingen (PI: SZ);
the Institutes of Clinical Psychology of the Universities of
Freiburg (PI: BTC) and Fribourg/Switzerland (PI: AH); and
the Integrated Research and Treatment Center Adiposity
Diseases of the University of Leipzig (PI: AH). The study
was advertised in the respective catchment areas of the
participating institutions in order to recruit a sufficient
number of participants.
A minimum of 70 participants finishing the study is
required for each study arm. With an expected dropout
rate of 20%, 175 participants needed to be recruited.
Overall, 178 participants were enrolled, and 89 were ran-
domized to each treatment condition. Between 10 and
36 participants were randomized at each of the 7 trial
sites.
To be included in the study, participants needed to be
18 years of age or older, have a body mass index (BMI) be-
tween 27 and 40 kg/m2, meet diagnostic criteria for BED
according to DSM-IV-TR or subsyndromal BED, and have
available internet access. To ensure generalization of study
results, exclusion criteria were kept to a minimum and are
listed below. Overall, 586 individuals were screened for
participation, of whom 408 did not meet inclusion criteria.
The most common reasons for nonparticipation were
BMI ≥40 kg/m2 (n = 105), BMI <27 kg/m2 (n = 65), on-
going psychotherapy (n = 40), not meeting diagnostic
criteria for BED or subsyndromal BED (n = 57), meeting
criteria for bulimia nervosa (n = 14), and lack of interest in
the study (n = 57).Inclusion criteria
 Diagnostic criteria for BED according to DSM-IV, or
 Subsyndromal BED: Patients have to meet the
criteria for OBEs but can lack one of the other
DSM-IV criteria (frequency of less than 2 days with
OBEs in 6 months, no marked distress, or presence
of only 2 instead of 3 of the 5 associated criteria)
 Age 18 years or older
 27 ≤ BMI < 40 kg/m2
 Written informed consent of the patient
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 Current bulimia nervosa
 Current substance abuse
 Current suicidal ideation
 Psychotic disorder
 Bipolar disorder
 Serious unstable medical problems or conditions
(for example, type 1 diabetes mellitus or thyroid
problems) that influence weight or eating
 Ongoing psychotherapy
 Current intake of antipsychotic or weight-affecting
drugs
 Pregnancy or lactation
Interventions
As mentioned above, therapy was given over a period of
4 months (with a maximum of 6 additional weeks). Each
therapist was responsible for both treatments, as a coach
in the GSH-I arm and as a therapist in the CBT arm.Table 1 Modules of the internet-based self-help [20]
Modules K
Module 1: Preparing for change (motivation module) •
•
•
•
•
Module 2: Observing yourself •
•
•
•
Module 3: Understanding and trusting yourself •
•
Module 4: Finding your own rhythm (Goal: A healthy meal pattern) •
•
•
Module 5: Building up your strategies •
•
Module 6: Physical activities •
•
Module 7: Identifying and solving your problems •
Module 8: Self-assertion •
•
Module 9: Handling your emotions •
Module 10: Changing the way you think •
•
•
Module 11: Continuing on your way •
•Prior to the start of treatment, therapists received train-
ing for the GSH-I (provided by TL) as well as training
for the CBT program (provided by AH).
Experimental intervention 1: internet-based guided self-help
(GSH-I)
For this intervention, the Self-Help Guide (Copyright ©
NetUnion & University Hospital of Geneva (HUG)) was
used. This program is based on an online program for buli-
mia nervosa following CBT principles that was developed
in the European Research Program SALUT by HUG and
NetUnion and adapted to specifically address BED [20].
The program was translated from French into German by
the INTERBED study team. It consists of 11 sequential
modules which are delivered within 4 months (see Table 1).
Participants work through the modules sequentially. After
predefined time intervals, the next module is made access-
ible to the participants by the coach (see Table 2).
Each module combines psychoeducation and behav-
ioral interventions and exercises that participantsey exercises/examples
Understanding the mechanisms that perpetuate the eating problem
Looking at self-esteem, mental attitude, and interpersonal relationships
Advantages and disadvantages of the current behavior
Imagining the future after successfully finishing the program
Conditions for change
My food diary
Food diary summary
Sabine’s day
Sabine’s food diary
The possibility of eating for pleasure
Food- and emotion-related triggers for compulsive eating
Eating regularly and according to my own rhythm
Finding my own preferences
Giving yourself time
How to prevent compulsive eating
Building my own strategy list
How to get started?
What is an “activity break”?
Learning how to solve a problem in separate steps
Making a place for yourself in the world
Using new assertiveness techniques
Automatic thoughts that trigger these emotions
Becoming more aware of certain cognitive distortions
Changing automatic thoughts into realistic thoughts
Applying these techniques to thoughts concerning food and your figure
Remembering what you have learned and preventing relapses
Using some tools in case of a misstep
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diary is introduced from the second module on and is
used throughout the duration of the treatment. Auto-
matic feedback generated by the program provides an
objective view of frequency and development of partici-
pants’ behavior. Two fictitious characters illustrate all
exercises and techniques. They demonstrate how to
complete exercises, explain difficulties, and give specific
examples to the participants. Some of the modules (that
is, relaxation and mindfulness) have audiotape files
attached to them for the participants to listen to.
Coaches can monitor participants’ progress and review
completed exercises, diary entries, and automatic feed-
back charts to ensure the correct use of the program.
Participants are instructed to contact their coach at least
once weekly by e-mail, and they receive feedback by
e-mail once weekly on a fixed day from the coach.
Coaches provide support and encouragement and
reinforce program participation through motivational
messages, as outlined in a coaches’ manual (written by
TL and FS) outlining the structure and content of the
e-mails, including sample e-mails, and giving instruc-
tions on how to handle unexpected emergencies (for ex-
ample, suicidality). Adherence to the content and
structure of the e-mails is supervised by an experienced
psychologist at the trial site in Erlangen-Nuremberg,
who gives written feedback to the coaches.
If participants do not enter the program or do not
write any e-mails for 3 weeks, the coaches call them on
the telephone to increase their motivation. After 4 weeks
without any connection, the participants’ program access
is canceled and participants are considered study
dropouts.
Coaches and participants meet in person twice for 90
minutes before the beginning and after the end ofTable 2 Frequency of therapy sessions/e-mail contacts in the
Month 1
GSH-I
Duration: 4 months 17–18
e-mails 2 face-to-face sessions
Frequency
of contact
One face-to face
contact with patien
One weekly e-mail
contact with patien
Time flow of the
intervention
modules
Module 1-3
Month 1
Individual CBT
Duration: 4 months 20
face-to-face sessions
Frequency
of contact
Twice weekly
face-to-face session
with patient
Time flow of the
intervention phases
Phase 1-2treatment. Both sessions are audiotaped. During the first
face-to-face session, the coaches explain the program’s
rationale to ensure the correct use of the internet pro-
gram. During the second face-to-face session, coaches
and participants briefly discuss treatment success and, if
necessary, further treatment options. After the end of
the treatment phase, the coach cancels participants’ ac-
cess to the program; however, all modules are available
for download in PDF format, and participants are
advised to print out the self-help material to have the
material available after the end of the guided treatment
phase.
To ensure confidentiality and data protection, the on-
line program uses a password-protected server, which is
located at NetUnion, Lausanne, Switzerland. Participants
receive a pseudonym and a password to access the on-
line program. For security reasons, they have to change
their password at first connection. An integrated messa-
ging system enables secured message exchange between
coaches and participants. E-mail addresses are protected
by one-way encryption. The website meets Health on
the Net Foundation (HON) quality and ethics standards
(http://www.hon.ch/).
Experimental intervention 2: cognitive-behavioral therapy
(CBT)
For this individual intervention, the existing manual in
German, “Binge Eating and Obesity: Cognitive-Behavioral
Therapy Manual for Binge Eating Disorder” by Hilbert
and Tuschen-Caffier [28] is used. The manual comprises
the following phases: (1) initial treatment phase for motiv-
ational enhancement; (2) intensive treatment phase, in-
cluding modules on eating behavior, body image, and
stress; and (3) self-management phase for relapse preven-
tion (Table 3).GSH-I and CBT conditions
Month 2 Month 3 Month 4
t
One weekly e-mail
contact with patient
One weekly e-mail
contact with
patient
One face-to face
contact with
patient
t
One weekly e-mail
contact with
patient
Module 3-6 Module 6-9 Module 9-11
Month 2 Month 3 Month 4
s
One weekly
face-to-face session
with patient
One weekly
face-to-face session
with patient
One weekly
face-to-face session
with patient
Phase 2 Phase 2 Phase 3
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pant’s individual symptomatology and resources. The in-
dividual outpatient treatment comprises 20 individual
sessions and lasts 4 months. Participants receive therapy
twice weekly for the first month and once weekly from
month 2 to month 4. The therapy sessions are held atTable 3 Modular cognitive-behavioral group therapy for bing
Therapeutic goals
Initial treatment phase
(sessions 1 to 3)
• Motivational enhancement
Intensive treatment phase
(sessions 4 to 17)
• Normalizing eating behavior
• Identification and modification
of dysfunctional thoughts and schemata
• Acquisition of new skills
• Establishment of regular
physical activity
Self-management phase
(sessions 18 to 20)
• Patients become their own therapists
• Maintaining progress in the future
• Relapse prevention
aFrom Hilbert and Tuschen-Caffier [28].the individual trial sites. The frequency of the sessions is
shown in Figure 1.
To evaluate the adherence to the CBT manual, a num-
ber of measures are assessed. First, to systematically as-
sess characteristics of form and content as well as
aspects of adherence of treatment, therapists completee eating disordera
Therapeutic interventions and techniques
• Psychoeducation
• Self-monitoring of food intake
• Development of an individual maintenance model
• Goal-setting
• Cognitive interventions for motivation
Eating Behavior Module
• Nutritional management
• Hunger and satiety perception training
• Cue exposure
• Hedonics exercise
• Cognitive interventions for negative schemata
related to eating behavior
Body Image Module
• Body image diary
• Body image exposure
• Exposure to avoided body-related situations
• Body hedonics exercise
• Shaping of regular physical activity
• Cognitive interventions for negative body-related schemata
Stress Module
• Stimulus and response control
• Stress management techniques
• Affect regulation techniques
• Interpersonal problem-solving
• Social competence training
• Cognitive interventions for further relevant negative schemata
• Exposure in case of further significant anxiety and avoidance
• Homework and practice
General techniques used in all modules
• Psychoeducation
• Self-monitoring
• Goal-setting
• Self-reinforcement
• Development of realistic expectations concerning
potential setbacks of binge eating
• Development of relapse prevention strategies
max.
2 wks
2  months 2 months
4 months  (+ 6 weeks allowed)
6 months
T0 T1 T2 T3
Beginning of treatment:
CBT: 1st treatment session
GSH-I: 1st face-to-face 
session
(activation of Internet 
program)
T1: Mid-treatment:
CBT: 10th session
GSH-I: 2 months
T2: End of treatment:
CBT: 20th session
GSH-I : 4 months, 2nd face-to-face 
session
(deactivation of  Internet program)
T3: Follow-up:
6 months after T2
(+/- 4 weeks allowed)
12 months
T4
T4: Follow-up:
12 months after T3
(+6/- 3 months 
allowed)
Follow-up: total 18 months 
Figure 1 Time points of measurement in the INTERBED study.
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The session reports give information regarding whether
the treatment session was conducted as scheduled or
was canceled by the participant, as well as whether the
session began on time or was delayed. Furthermore, the
session reports show the duration of the session, the pri-
mary and secondary foci of interventions (for example,
self-monitoring), the use of manualized treatment mater-
ial, reasons for nonadherence to the agenda, accom-
plishment of homework by the participant, and the
cooperation of the participant as rated by the therapist.
An individual study therapy is considered to have been
conducted according to the manual if a participant
attends at least 12 of 20 treatment sessions.
Second, all CBT sessions are audiotaped if participants
give their consent. One of four consecutive audiotapes
of each participant is randomly chosen and checked with
regard to manual adherence using a checklist on con-
tent, the material worked on, and formal characteristics
(for example, duration of the session). Nearly all partici-
pants gave their written informed consent for audio-
taping of their therapy. Interrater reliability of the
adherence coding will be determined.
Objectives and hypotheses
The objectives of the study are to assess the short- and
long-term efficacy of internet GSH-I compared to indi-
vidual CBT with respect to the number of days with
OBEs and with respect to secondary outcomes of treat-
ment, to investigate moderators and predictors of thera-
peutic change, and to determine cost-effectiveness.In accordance with the primary objective, the GSH-I
arm is expected to show no significant inferiority regard-
ing the decrease in the number of days with OBEs com-
pared to the CBT condition. The study is designed as a
noninferiority trial with a noninferiority margin of 1 day
with OBEs (d) in favor of CBT. Given a lack of research
supporting an evidence-based noninferiority margin
at the time of study planning, this margin has been
agreed upon in discussions with clinical experts. The
null hypothesis tested in the confirmatory analysis is
(H0) Δ GSH-I <Δ CBT-d with the alternative hypothesis
of (H1) Δ GSH-I ≥Δ CBT-d. It is also expected that there
will be no significant difference in secondary outcomes be-
tween participants of the GSH-I and the CBT condition.
Primary and secondary outcomes
The primary outcome will be the difference in the num-
ber of days with OBEs over the past 28 days. The diag-
nostic criteria for BED focus on days per week with
OBEs rather than on individual episodes, the rationale
being that, in the absence of purging behavior, BED par-
ticipants may have more difficulty than patients with
bulimia nervosa recalling discrete binge eating episodes.
Number of days with OBEs is measured using the
German version of the Eating Disorder Examination
(EDE) [29,30], a semistructured interview which is
regarded as the gold standard assessment of eating dis-
order psychopathology. Comparisons will be made be-
tween baseline (randomization, T0), midtreatment (T1),
and the end of treatment (T2). In addition, maintenance
of treatment outcome will be assessed 6 and 18 months
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groups (T3 and T4).
Secondary outcome measures are the associated eating-
related psychopathology measured using the EDE subscales
(restraint, eating concerns, shape and weight concerns)
[29,30] and the Dutch Eating Behavior Questionnaire
(DEBQ) [31,32], psychiatric comorbidity assessed using the
Structured Clinical Interview for DSM-IV diagnoses
(SCID-I) [33], severity of depression measured using the
Beck Depression Inventory II (BDI-II) [34,35], and self-
esteem measured using the Rosenberg Self-Esteem Scale
(RSE) [36,37]. Quality of life will be measured using the
Impact of Weight on Quality of Life Scale-Lite (IWQOL-
Lite) [38,39], physical activity will be measured using the
International Physical Activity Questionnaire (IPAQ) [40],
and BMI will be calculated from measured weight and
height (kg/m2).
For all self-report instruments used in the study, suffi-
cient psychometric properties of the German versions
have been demonstrated. Measurement time points are
shown in Figure 1, and assessment of secondary out-
come measures are given in Table 4.
Predictor variables
Moderator and nonspecific predictor variables are
assessed pretreatment and include the severity of eating
disorder and general psychopathology, which are opera-
tionalized through the EDE total score and the BDI-II.
In addition, as nonspecific predictors (that is, pretreat-
ment measures that may have a main effect on outcome
but no interactive effect with treatment), frequency of
binge eating, specific aspects of eating disorder psycho-
pathology, psychiatric comorbidity, age at onset of eating
disorder and overweight, self-esteem, and quality of life
are assessed (EDE, DEBQ, SCID-I, RSE, and IWQOL).
In addition, patient expectations and motivation are
assessed using visual analogue scales (see [41]).Table 4 Assessment of secondary outcome measures in the IN
Baseline Midtreatment E
2 months after randomization 4 mont
EDE X X
DEBQ X X
SCID-I X
BDI-II X X
RSE X X
IWQOL X X
IPAQ X X
BMI X X
aBDI-II = Beck Depression Inventory, DEBQ = Dutch Eating Behavior Questionnaire, E
Questionnaire, IWQOL = Impact of Weight on Quality of Life–Lite, RSE = Rosenberg S
Diagnoses.The process variables include variables previously
shown to promote changes in face-to-face CBT such as
a rapid reduction of binge eating during the early treat-
ment phase, a decrease in weight concerns, and the non-
specific factor of therapeutic alliance. These variables are
assessed using (1) the EDE at midtreatment; (2) items
from the self-report form of the EDE, the Eating
Disorder Examination-Questionnaire (EDE-Q) [42,43],
which is administered to patients every week (nine items
on binge eating and eating disorder psychopathology);
and (3) the Working Alliance Inventory-Short Version
(WAI-S) [44,45], which is administered to patients at the
end of each CBT session and weekly in the GSH-I condi-
tion. Therapeutic alliance proved to be a common ingre-
dient of all psychotherapeutic interventions and to be at
least modestly correlated with outcomes in the treat-
ment of many disorders, including bulimia nervosa
[46,47]. However, almost nothing is known about how
the therapeutic relationship operates online.
The continuous application of the session reports will
allow examination of the process of change during treat-
ment. We expect no differential course of these factors
between the two treatment conditions.Cost-effectiveness
In an associated project, the cost-effectiveness of treat-
ment is being assessed by calculating the direct and in-
direct costs of both treatment conditions prior, during,
and after therapy. By using the Client Sociodemographic
and Service Receipt Inventory (CSSRI) [48], the overall
health resource utilization of participants as well as
productivity losses will be operationalized. To estimate
costs, these quantities will then be valued on the basis of
market prices. If market prices are not available, admin-
istrative prices or mean costs will be used to estimate
so-called “shadow prices.”TERBED studya
nd of treatment Follow-up
hs after randomization 10 and 22 months after randomization
X X
X X
X
X X
X X
X X
X X
X X
DE = Eating Disorder Examination, IPAQ = International Physical Activity
elf-Esteem Scale, SCID-I = Structured Clinical Interview for DSM-IV, Axis I
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To test for noninferiority of the GSH-I intervention to-
ward CBT regarding the number of days with OBE epi-
sodes over the past 28 days, we specified a noninferiority
margin of 1 day in favor of CBT. For sample size calcu-
lations, we followed a conservative statistical approach.
Assuming a standard deviation of 2.1 days in both
groups for the number of binge eating days over the
evaluation period (which lies within the range of those
observed in previous clinical trials), a sample size of at
least 70 participants per group was required for the con-
firmatory analysis to guarantee statistical power of 80%
when testing for noninferiority by applying a two-sample
t-test. Allowing for a dropout rate of 20% of study parti-
cipants from T0 to T2, 175 participants need to be
recruited overall.Randomization
Individuals who met the respective inclusion criteria and
who gave their written informed consent to participate
were randomized. There were no stratification criteria.
To ensure the concealment of allocation, randomization
was performed centrally by fax by the Coordination
Center for Clinical Trials (KKS) in Marburg. Eligibility
assessment, obtaining informed consents, and enrolling
the participants in the study were done at the respective
study centers.Blinding
Treatment and assessment were separated. Therapists
and coaches are not involved in assessing treatment out-
come, and assessors are not allowed to hold treatment
sessions or write e-mails. The statistician who will
conduct the statistical analyses was not involved in
randomization. Treatment allocation is not disclosed to
the statistician until all data checks are completed.Statistical analysis
The statistical analysis of the primary end point (number
of days with OBE episodes within the past 28 days) will
follow a two-step approach. First, a confirmatory analysis
of the difference of OBE days from baseline (T0) to the
end of treatment (T2) will test for noninferiority of the
GSH-I intervention compared to CBT, taking a noninfer-
iority margin of 1 day with OBEs into account. For the
noninferiority hypothesis, the per-protocol approach is
employed to avoid a bias toward equivalence resulting
from intent-to-treat in this specific setting [49]. If the
difference of days asymptotically follows a normal distri-
bution, a standard two-sample t-test (applying Welch’s
correction if different within-group variance appears)
will be applied. If the distributional assumption cannotbe confirmed on the basis of the observed data, the non-
parametric Wilcoxon signed-rank test will be applied.
In a second step, we will carry out an explanatory lon-
gitudinal and multivariable regression analysis, taking
the absolute number of OBE days within the past 28
days throughout the study from baseline (T0) to follow-
up (T3 and T4) into account, adjusting for possible non-
specific predictor variables such as sociodemographic
characteristics as well as secondary outcome measures.
An advantage of this approach is that we can addition-
ally detect possible moderator and mediator effects in-
fluencing treatment outcome [50,51].
As the outcome variable reflects interval count data in
a longitudinal setting, we will apply random coefficients
modeling of a Poisson regression model [52]. The advan-
tage of this state-of-the-art modeling approach is its
ability to incorporate heterogeneity of effects (for ex-
ample, center-specific or subject-specific) and its toler-
ance to missing data. Although standard approaches
based on relative change rely on complete cases, this
longitudinal modeling approach builds up a design
matrix with one row for each measurement instead for
each patient. A missing outcome at the end of treatment
therefore does not necessarily lead to the deletion of the
patient from the analysis.
The model, incorporating the log-link as canonical link
for the expected value of the Poisson distribution, can
be written as follows:
log Yij
  ¼ θi þ treatmenti:timej þ xTi βþ zTij γ
where Yij denotes the number of OBE days of patient i
(i = 1, . . ., n) at time point j ∈ (j {0,1,2,3}); θi is a subject-
specific random intercept (following a gamma distribu-
tion); treatmenti · timej is the treatment effect at differ-
ent time points (where baseline is coded as 0); zij
Tγ
represents additional subject-specific, time-constant
effects (including possible nonspecific predictor variables
that were assessed pretreatment, such as age at onset of
eating disorder and overweight); and zij
Tγ denotes covari-
ates varying over time that might be possible mediators
of treatment outcome (considered as the severity of eat-
ing disorder and general psychopathology, assessed using
the EDE total score and the BDI-II). To account for the
possibility of moderator effects, additional interaction
terms treatmenti · zij can be included for postbaseline
measurements (if j ≠ 0). Variable selection will be based
on likelihood ratio statistics of nested models.
If the assumption of equal Poisson variation cannot be
confirmed and significant over- or underdispersion is
present, we consider as an alternative the negative bino-
mial distribution [53] with density:
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  ¼ Γ Yij þ σ
 
Γ Yij þ 1
 
Γ σð Þ
:
μij
σ
 Yij
μij
σ þ 1
 Yijþσ
 
Here σ is a constant variation parameter, Г(·) expresses
the gamma function and log(μij) is modeled by the same
additive predictor as described above for the Poisson dis-
tribution. If the variation term depends on the time
point or other covariates, we will apply generalized addi-
tive models for location, scale, and shape (GAMLSS)
[54], and we will also model log(σij) with a subject-
specific random term [55].
Consistent with previous research [19,41], the analyses
will include three categorical outcomes, all determined
at posttreatment and follow-up time points: recovered
(no OBEs in the past month), improved to subclinical
binge eating (less than 4 days with OBEs in the past
month), and being at or below a comparative level of
eating disorder attitudes and behaviors. The latter rating
will be made on the basis of whether the global EDE
score is at or below the global EDE score of overweight
non-BED treatment-seeking individuals with a sociode-
mographic profile similar to that of the patients in the
current study.
Secondary end points will be analyzed in an explana-
tory analysis comparing differences between the two
treatment groups at T1 and T2, followed by further mul-
tivariable regression analyses for cases where differences
were detected.
All statistical analysis will be carried out using the
open source statistical programming environment
R 2.14.2 [56], which provides greater flexibility and far
more modeling options than standard commercial soft-
ware packages.
Safety aspects
An independent Data Monitoring and Safety Committee
(DMSC) was established, which meets once per year.
The DMSC is composed of four researchers familiar
with the area of the study. The type of information mon-
itored includes patient recruitment, number of dropouts,
and all adverse events, including study withdrawals. Any
serious adverse events (SAEs) are immediately reported
to the PI (MdZ) and the Ethics Committee at the site
and are forwarded to the DMSC. All fatal or life-
threatening events are defined as SAEs. The DMSC
receives recruitment and retention updates on a regular
basis from the data center (KKS). The committee pre-
pares a brief report based on the material received,
which includes recommendations to the PIs as to
whether the continuation of the study is justifiable in
view of the number and degree of reported SAEs and
the recruitment and follow-up rates are sufficient to
guarantee the necessary statistical power.Data management
Case report forms (CRFs) were developed using
scannable forms, and a study database was set up. All
pseudonymized data from patients are stored at the
Coordinating Center for Clinical Trials (KKS) in
Marburg. Data quality management includes automatic
data checks, queries, query handling, and audit trail. All
study-related CRFs will be stored for 10 years in the
archives of the respective trial site.
Quality control/monitoring
As an instrument for quality control and quality assur-
ance, the clinical trial is monitored. Monitoring is per-
formed by a psychologist (FS) who has attended a
university-based course on good clinical practice (ICH-
GCP) and has attained a certificate for monitoring clin-
ical studies. She is supervised by the KKS at the Univer-
sity of Marburg. Monitoring is performed according to
the standard operating procedures (SOPs) from the KKS
at the University of Marburg. Each trial site receives a
minimum of three monitoring visits, including an initi-
ation visit and a close-out visit. The purposes of the
monitoring are to verify that the rights of the partici-
pants are protected; that the reported trial data are
accurate, complete, and verifiable in the source docu-
ments; and that the conduct of the trial follows ICH
GCP criteria, the study protocol, and its amendments.
For every on-site visit, a monitoring report is written
and reviewed by the KKS.
Ethical considerations
The study uses rigorous methodology as required by the
funding agency. It is conducted in accordance with ICH
GCP and CONSORT criteria. A corresponding declar-
ation had to be submitted comprising the assurance that
the trial will be conducted in accordance with the princi-
ples of ICH GCP and that the medical institution of the
PI of the study will assume the sponsor’s responsibilities
in accordance with chapter 5 of ICH GCP. In addition,
the study is being carried out in accordance with the lat-
est version of the Declaration of Helsinki.
The final study protocol and the final version of the
written informed consent form were approved by the
Ethics Committee of the Medical School of the Univer-
sity of Erlangen-Nuremberg, the site where the PI was at
the time of the beginning of the study (Ref. No. 4081).
Approval from the Ethics Committee was obtained prior
to patient enrollment at all trial sites. All protocol modi-
fications are submitted to each Ethics Committee for ap-
proval before implementation.
Results and discussion
INTERBED is the first study comparing GSH-I with
standard face-to-face CBT in patients with BED. Self-
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self-help interventions have been shown to be effective
in the treatment of BED; however, direct comparisons
with CBT are missing.
Furthermore, although CBT is the best-established
intervention for BED, until now there have been no con-
trolled multicenter trials conducted in German-speaking
countries that have shown the efficacy of this interven-
tion. As BED is still a recent diagnostic category, many
cases likely remain undiagnosed, and a large number of
patients either receive delayed treatment or never get
adequate treatment. A multicenter efficacy trial will ad-
vance the dissemination of this evidence-based gold
standard treatment in Germany.
Perkins et al. [57] summarized in the Cochrane review
that, at present, RCTs on self-help in eating disorders
are mostly manual-based treatments in book format.
Other media for delivering self-help need to be explored
as well: “In particular, approaches using new technolo-
gies such as the Internet need to be researched further,
as they are likely to be more interactive and hence may
be more attractive to patients than manual-based
approaches” [57]. The German Society for the Internet
in Medicine recommends that new technologies such as
the internet should be researched further. According to
the German Federal Statistical Office, mobile phones,
computers, and the internet have become integral parts
of our society [58]. Currently, 75% of German adults are
using the internet at home or at the workplace [59].Conclusions
The detailed methodology for the INTERBED study has
been presented. The INTERBED study tries to exclude
numerous methodological shortcomings from the outset.
In conclusion, the INTERBED study will help to clarify
the short- and long-term efficacy of internet-based self-
help in comparison to an international gold standard
therapy in the treatment of BED. The study will contrib-
ute to the dissemination of evidence-based treatment
options of BED in Germany. INTERBED will contribute
to the specification of how to match patients to
treatment.
The study was conducted in accordance with GCP and
CONSORT criteria and followed the ethical principles
described in the current revision of the Declaration of
Helsinki, thus applying highest methodological and eth-
ical standards to a multisite psychotherapy trial that
includes face-to-face as well as internet-based treatment
approaches.
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